|
|
|
| Correlation between Serum Galectin 3 Level and Recurrence after Radiofrequency Ablation in Patients with Atrial Fibrillation |
| ZHOU Na, CHEN Jun-min |
| Department of Cardiology, Xianyang Hospital of Yan 'an University, Xianyang 712000 |
|
|
|
|
Abstract 【Objective】 To investigate the correlation between galectin-3 (Gal-3) and recurrence after radiofrequency ablation in patients with atrial fibrillation.【Methods】The clinical data of 90 patients with atrial fibrillation treated by radiofrequency ablation in the Department of Cardiology of our hospital from June 2016 to June 2018 were selected. They were divided into recurrence group (n=27) and non recurrence group (n=63) according to whether they relapsed after operation. The concentration of serum Gal-3 was detected by sandwich enzyme-linked immunosorbent fluorescence method, and the effect of serum Gal-3 level on the recurrence of atrial fibrillation after ablation was analyzed by Cox regression model.【Results】Among the 90 patients with atrial fibrillation, 48 patients (53.3%) had persistent atrial fibrillation, and 24.4% had CHA2DS2 -VASC score>2. Warfarin was the main anticoagulant (60.0%). There were significant differences in age, type of atrial fibrillation, CHA2DS2-VASC score, left atrial diameter (LAD), serum amino terminal B-type pro-brain natriuretic peptide (NT-proBNP), high-sensitivity C-reactive protein (hs-CRP) and Gal-3 between recurrent group and non recurrent group (P<0.05). Univariate Cox regression analysis showed that age, LAD, persistent atrial fibrillation and the levels of serum Gal-3 and hs-CRP were the risk factors for postoperative recurrence of atrial fibrillation (P<0.05). Multivariate Cox regression analysis showed that persistent atrial fibrillation, LAD and serum Gal-3 and hs-CRP levels were independent risk factors for recurrence after RFCA in patients with atrial fibrillation (P<0.05).【Conclusion】The level of serum Gal-3 is an independent risk factor for recurrence after RFCA in patients with atrial fibrillation.
|
|
Received: 06 May 2019
|
|
|
|
|
|
[1] ZUNGSONTIPORN N, LINK M S . Newer technologies for detection of atrial fibrillation[J].BMJ,2018,363:k3946.
[2] BLOMSTRÖM-LUNDQVIST C, GIZURARSON S, SCHWIELER J, et al. Effect of catheter ablation vs antiarrhythmic medication on quality of life in patients with atrial fibrillation: the captaf randomized clinical trial[J].JAMA,321(11):1059-1068.
[3] KUCK K H, BRUGADA J. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation[J].N Engl J Med,2016,374(23):2235-2245.
[4] CHEN D, PROCTER N, GOH V, et al. New onset atrial fibrillation is associated with elevated galactic-3 levels[J].Int J Cardiol,2016,223:48-49.
[5] NAVIN S,MEIJERS W C,SILLJÉ HERMAN H W,et al. Galectin-3 activation and inhibition in heart failure and cardiovascular disease: an update[J].Theranostics,2018, 8(3):593-609.
[6] HO J E, YIN X, LEVY D, et al. Galectin 3 and incident atrial fibrillation in the community[J].Am Heart J,2014, 167(5):729-734.
[7] CLEMENTY N, BENHENDA N, PIVER E,et al. Serum Galectin-3 Levels Predict Recurrences after Ablation of Atrial Fibrillation[J].Sci Rep,2016, 6:34357.
[8] 黄荫浩,于小红,徐海霞,等.射频消融术后房颤患者血清hs-CRP、NT-ProBNP、CTnI水平变化及其与房颤复发的相关性分析[J].医学临床研究,2018,35(11):2227-2229.
[9] 周立宾,薛红.ACS患者血清IMA、Hcy、NT-proBNP水平变化及其诊断[J].医学临床研究,2019,36(1):175-176.
[10] KORNEJ J, SCHMIDL J, UEBERHAM L,et al. Galectin-3 in patients with atrial fibrillation undergoing radiofrequency catheter ablation[J].PLoS One,2015, 10 (4): e0123574.
[11] MARROUCHE N F, WILBER D, HINDRICKS G, et al. Association of Atrial Tissue Fibrosis Identified by Delayed Enhancement MRI and Atrial Fibrillation Catheter Ablation[J].JAMA,2014, 311(5):498-506.
[12] SRAMKO M, PEICHL P, WICHTERLE D, et al. Clinical value of assessment of left atrial late gadolinium enhancement in patients undergoing ablation of atrial fibrillation[J].Int J Cardiol,2015, 179:351-357. |
|
|
|
2021, Vol. 38 
